Corline Biomedical AB (STO:CLBIO)

Corline Biomedical AB Statistics

Total Valuation

STO:CLBIO has a market cap or net worth of SEK 475.62 million. The enterprise value is 442.72 million.

Market Cap	475.62M
Enterprise Value	442.72M

Important Dates

The next estimated earnings date is Wednesday, August 26, 2026.

Earnings Date	Aug 26, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:CLBIO has 26.13 million shares outstanding. The number of shares has increased by 10.88% in one year.

Current Share Class	26.13M
Shares Outstanding	26.13M
Shares Change (YoY)	+10.88%
Shares Change (QoQ)	+0.60%
Owned by Insiders (%)	45.06%
Owned by Institutions (%)	16.65%
Float	11.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	44.60
PB Ratio	4.74
P/TBV Ratio	18.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-31.30
EV / Sales	41.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-24.72

Financial Position

The company has a current ratio of 6.41

Current Ratio	6.41
Quick Ratio	6.13
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-14,216.00

Financial Efficiency

Return on equity (ROE) is -15.35% and return on invested capital (ROIC) is -9.64%.

Return on Equity (ROE)	-15.35%
Return on Assets (ROA)	-8.65%
Return on Invested Capital (ROIC)	-9.64%
Return on Capital Employed (ROCE)	-12.97%
Weighted Average Cost of Capital (WACC)	5.92%
Revenue Per Employee	888,583
Profits Per Employee	-1.18M
Employee Count	12
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +76.70% in the last 52 weeks. The beta is 0.30, so STO:CLBIO's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	+76.70%
50-Day Moving Average	16.34
200-Day Moving Average	16.59
Relative Strength Index (RSI)	61.68
Average Volume (20 Days)	16,699

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:CLBIO had revenue of SEK 10.66 million and -14.14 million in losses. Loss per share was -0.57.

Revenue	10.66M
Gross Profit	8.83M
Operating Income	-14.22M
Pretax Income	-14.14M
Net Income	-14.14M
EBITDA	-14.12M
EBIT	-14.22M
Loss Per Share	-0.57

Balance Sheet

The company has 32.90 million in cash and n/a in debt, with a net cash position of 32.90 million or 1.26 per share.

Cash & Cash Equivalents	32.90M
Total Debt	n/a
Net Cash	32.90M
Net Cash Per Share	1.26
Equity (Book Value)	100.45M
Book Value Per Share	3.92
Working Capital	34.63M

Cash Flow

In the last 12 months, operating cash flow was -17.51 million and capital expenditures -404,000, giving a free cash flow of -17.91 million.

Operating Cash Flow	-17.51M
Capital Expenditures	-404,000
Depreciation & Amortization	99,000
Net Borrowing	9.13M
Free Cash Flow	-17.91M
FCF Per Share	-0.69

Margins

Gross margin is 82.80%, with operating and profit margins of -133.32% and -132.65%.

Gross Margin	82.80%
Operating Margin	-133.32%
Pretax Margin	-132.65%
Profit Margin	-132.65%
EBITDA Margin	-132.39%
EBIT Margin	-133.32%
FCF Margin	n/a

Dividends & Yields

STO:CLBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.88%
Shareholder Yield	-10.88%
Earnings Yield	-2.97%
FCF Yield	-3.77%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2